Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603807653/en/Byondis-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-Novel-SIRP-Directed-Monoclonal-Antibody-BYON4228-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors
24 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250324077182/en/Byondis-Appoints-Christoph-Korpus-PhD-MBA-as-Chief-Business-Officer
19 Nov 2024
// BUSINESSWIRE
19 Nov 2024
// BUSINESSWIRE
16 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-food-and-drug-administration-issues-complete-response-letter-for-byondis-vic-trastuzumab-duocarmazine-301824573.html
25 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/byondis-initiates-phase-i-study-of-next-generation-antibody-drug-conjugate-byon3521-301611571.html
ABOUT THIS PAGE
Byondis is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Duocarmazine bulk with DMF offered by Byondis